🇺🇸 FDA

Company profile · Sponsor

Meda

Meda AB

ECB065A · EMA pharma EU
Pipeline
7
Drugs
0
Patents
0

Quick answer

Meda (ECB065A) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ECB065A
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (7)

Search pipeline →

  1. Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG

    Meda

    Mild Cognitive impairment due to Alzheimer Disease

    phase 2 small molecule active

    1 trial

  2. Olumiant 2 mg film-coated tablets, Maltodextrine powder

    Meda

    Human immunodeficency virus

    phase 2 small molecule active

    1 trial

  3. PALONOSETRON, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, Plitidepsin, DEXCHLORPHENIRAMINE, PLACEBO

    Meda

    post-COVID-19 Condition (PCC)

    phase 2 small molecule active

    1 trial

  4. Pacritinib

    Meda

    Patients with myelofibrosis and platelets counts between 50 - 120 x 10e9/L

    phase 2 small molecule active

    1 trial

  5. Veklury 100 mg powder for concentrate for solution for infusion

    Meda

    COVID-10 infection

    phase 2 small molecule active

    1 trial

  6. BENZATHINE BENZYLPENICILLIN , LINEZOLID

    Meda

    Syphilis

    approved small molecule active

    1 trial

  7. Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Pifeltro 100 mg film-coated tablets

    Meda

    Human Immunodeficiency Virus

    approved small molecule active

    1 trial

Frequently asked questions

What is Meda?

Meda (ECB065A) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Meda sponsor?

We track 7 ClinicalTrials.gov-linked programs for Meda, including Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Meda company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.